Who Owns NVA in 2026—and What It Means if You’re Selling to Them

Key takeaways

• JAB is the ultimate owner. NVA is the operating company, and published records describe JAB as a privately held investment group controlled by the Reimann family.
• NVA and Ethos are distinct platforms. The 2023 separation placed general-practice operations with NVA and specialty-and-emergency operations with Ethos, while both remained connected to JAB.
• The contract name matters. A seller should identify the acquisition entity, guarantor if any, rollover issuer, and party responsible for each continuing obligation.
• FTC provisions have boundaries. The cited orders cover specialty-and-emergency acquisitions within specified distances and jurisdictions, not every NVA general-practice purchase.
• Rollover equity needs its own diligence. Its rights and future value depend on governing documents and later events; liquidity, timing, return, and control are not promised.

The letter landed between the water glasses before we ordered. An owner had received an NVA introduction and wanted to ask one deceptively simple question: “Who is actually on the other side of this?”

I turned the page over. The logo answered who made the approach, but it did not answer who owned the platform, which entity might sign, or what a retained investment would follow.

She had circled the sender’s name and drawn an arrow toward the signature block, a small mark that captured the hidden issue. Brand recognition answers identity, not accountability.

Before the appetizers arrived, we sketched a short row of boxes on a napkin: family-controlled investor, platform operator, acquisition vehicle, and rollover issuer. The letter looked less simple.

That napkin was not an organization chart. It was a reminder to request one before confidential records moved.

NVA is owned by JAB, a privately held investment group controlled by the Reimann family. JAB acquired NVA in 2019.

NVA later separated its general-practice operations from the Ethos specialty-and-emergency platform. Current company and sponsor records still place both within JAB’s orbit, while their operating roles remain distinct.

If you searched “NVA private equity owner,” the name you wanted was JAB. The more useful seller question is how that owner, NVA’s operators, and the acquisition entity connect.

Who owns NVA in 2026?

JAB is NVA’s ultimate owner and investor, while NVA is the operating company for its general-practice and related platform.

Published records describe JAB as controlled by the Reimann family, but they do not support claiming that JAB owns every share or that the family manages NVA day to day.

An ultimate owner tops the ownership chain, while an operating company runs the platform through its own leaders, teams, systems, contracting entities, and daily decisions, with distinct jobs at each level.

Draw the map plainly: the Reimann family controls JAB, JAB owns NVA, and NVA operates the veterinary platform beneath that investor, with distinct legal counterparties filling specific roles along the way, so every layer matters.

Two trade accounts line up: PE Professional described JAB in 2019 as a privately held Reimann-controlled group, while AVMA independently reported the family’s ownership when covering NVA’s acquisition. The chain was corroborated.

Those reports said NVA management retained a minority interest, meaning an ownership stake smaller than the controlling position that, on its own, neither establishes control nor reveals today’s precise capitalization, leaving those details private.

I would not turn those historical descriptions into a current ownership percentage, because public evidence answers the control question at JAB’s level without disclosing every detail beneath it today, which is why restraint matters.

The freshest sponsor-side signal here comes from JAB’s newsroom, which carried NVA’s April 24, 2026 chief financial officer appointment and kept the platform in JAB’s portfolio announcement channel, keeping that current link visible.

For a seller, the ownership answer is only the first layer; the separate NVA buyer profile covers acquisition and integration context without confusing that operating work with JAB’s investor role, keeping the boundary clear.

Layer	Name	Role	Seller question
Ultimate owner	JAB	Investor and holding company	What approvals sit above NVA?
Operating company	NVA	General-practice platform	Which NVA entity leads the process?
Separate platform	Ethos	Specialty and emergency platform	Is Ethos involved at all?
Acquisition entity	Name in the documents	Buyer of assets or interests	Who owes each obligation?

The last row changes every time, because a familiar brand can introduce the conversation while a differently named legal entity appears in the letter of intent or purchase agreement, making the signature page decisive.

How did JAB become NVA’s owner in 2026?

JAB’s NVA ownership began with a 2019 transfer from Ares Management and OMERS Private Equity, announced on June 17 with closing expected in the third quarter of that year.

Contemporary reports said NVA management retained minority ownership, so the historical record supports control by JAB without proving that every share moved to one owner; precision stops there.

PE Professional reported that NVA then had more than 670 companion-animal hospitals and 70 pet resorts across 43 U.S. states, plus locations in Canada, Australia, and New Zealand.

The same report counted more than 14,000 employees and 2,600 veterinarians, describing the platform at the ownership transfer rather than NVA’s current composition, a scale that changes over time.

AVMA’s 2019 account likewise reported more than 670 hospitals and 70 pet resorts, while saying management kept a significant minority interest. Two reports, same essential chain.

The seller lesson is not that a 2019 transaction dictates a 2026 offer; it is that sponsor ownership and operating management are separate facts shaping approvals, offering context rather than prophecy.

When I review an ownership chain over dinner, I place every date beside it so an old transaction cannot masquerade as a current promise or undisclosed commitment in a live process. Dates discipline the story.

The sequence is straightforward:

• Before 2019. Ares Management and OMERS Private Equity held NVA.
• June 17, 2019. Their sale of NVA to JAB was announced.
• Third quarter of 2019. The announcement expected the transfer to close in that period.
• April 24, 2026. JAB’s newsroom still carried an NVA leadership appointment.

Start with that chronology. It does not disclose every intermediate entity, approval right, or minority holder, but it gives an owner a factual foundation and a list of details to verify in the transaction documents.

What is the relationship between NVA and Ethos in 2026?

NVA and Ethos are not one operating company after the 2023 separation: NVA held general-practice and related operations, while Ethos Veterinary Health held the specialty-and-emergency platform as a distinct operator.

Both remained connected to JAB, and NVA materials still present Ethos as a distinct division, so sellers must keep the shared owner and separate operating roles in view.

AVMA reported in May 2023 that NVA formed 2 operating platforms: Ethos combined 145 specialty hospitals; NVA held general practice, pet resorts, and equine operations, a split that still matters.

That historical structure statement does not make every brand or entity interchangeable now. Shared ownership does not erase operating boundaries after the split.

NVA’s current site describes 1,000 community hospitals in General Practice and more than 140 hospitals in Ethos Specialty & ER; it lists Pet Resorts and Equine as other divisions.

A September 8, 2025 NVA leadership release named John Bruno chief executive officer, succeeding Larry Allgaier, and used a broader figure of approximately 1,300 locations across all divisions, showing why scope matters.

The figures are not like-for-like: one breaks out divisions, while the other describes the combined footprint, so I attribute each count and date to explain the gap in scope.

The 2023 AVMA report said both platforms were positioned to pursue IPOs within 2 to 3 years, but that was dated positioning, not proof of a filing, timetable, or guaranteed outcome; history is not destiny.

An owner selling a companion-animal general practice should expect NVA to matter most, yet the contract controls, so verify every entity instead of inferring it from a website chart; the contract comes first.

What does JAB’s ownership structure mean for an NVA seller in 2026?

JAB’s structure means a seller should separate holding-company ownership from a conventional fixed-life private equity fund. Published sources describe JAB as privately held and family-controlled.

They do not establish a fixed JAB exit deadline, a promised NVA holding period, or direct Reimann-family management of the operating company. Those claims should never be inferred.

That contrast has a benchmark.

CFO.com explains that a conventional private equity fund commonly has a standard 10-year lifecycle, useful context precisely because published descriptions place JAB in a different holding-company category without an inferred deadline.

Different structure does not tell us whether JAB will hold, sell, recapitalize, or pursue another path. Ownership form is a diligence prompt, not a prediction engine.

For a seller, the practical questions sit one level lower. Who approves the transaction?

Which entity funds it? Which entity issues rollover equity?

What happens to continuing rights if ownership changes?

The broader veterinary consolidator directory can help an owner understand the buyer field. It should not replace transaction-specific diligence on the buyer already at the table.

I also separate platform events from practice operations. A financing, leadership appointment, ownership transfer, or public listing may change the platform’s capital structure without dictating what happens inside one hospital.

Place each promise beside the entity that makes it. If NVA describes an operating plan, confirm which NVA entity carries it.

If rollover is offered, identify the issuer and governing documents.

Ask for a simple ownership chart. Then ask counsel to trace the names in that chart through the letter of intent, definitive agreement, rollover documents, and any guaranty.

That is not suspicion. It is ordinary entity diligence whenever the brand, operating company, acquisition entity, and ultimate owner are not the same legal person.

Do the FTC orders affect an NVA sale in 2026?

The cited FTC orders are not universal restrictions on NVA acquisitions. They concern covered specialty-and-emergency clinic acquisitions, specified distances, named jurisdictions, and 10-year approval or notice periods created in 2022.

A companion-animal general-practice owner should not assume the orders apply. The specific services, location, buyer entity, and transaction still need a transaction-specific legal check.

Two terms set the boundary.

Prior approval means affirmative regulator permission before a covered acquisition may close; prior notice means advance written notice before a different covered acquisition within the order’s defined scope and duration.

Paul Hastings described the June 13, 2022 SAGE order as requiring prior approval for 10 years on covered specialty-and-emergency acquisitions within 25 miles of existing JAB clinics in California or Texas.

It also described a 30-day prior-notice requirement, lasting 10 years, for covered specialty-and-emergency acquisitions within 25 miles of any JAB clinic nationwide.

AVMA’s coverage of the two 2022 FTC actions described the combined prior-approval footprint as California, Colorado, the District of Columbia, Maryland, Texas, and Virginia. The record covered specialty-and-emergency clinics.

AVMA reported that 11 clinics were divested across the two actions. Those historical remedies explain the orders’ origin; they do not convert the provisions into a rule for every NVA general-practice transaction.

For the reader this article serves, the boundary is the important part. Do not assume a general-practice sale is restricted merely because NVA and JAB appear in the same ownership chain.

If a proposed transaction includes services or entities outside the straightforward companion-animal general-practice scope, let counsel read the actual order and proposed structure. This section is process context, not legal advice.

What should a seller verify about the buyer entity in 2026?

Verify the specific acquisition entity, its relationship to NVA and JAB, the signer, any guarantor, the rollover issuer, and the party responsible for each continuing obligation.

The logo on an outreach letter is not enough. Match every promise to the legal name and document that makes it enforceable, with legal and tax advisers reviewing the final structure.

An acquisition entity is the legal entity named as buyer of the practice assets or ownership interests. It may share NVA branding without being the operating company or ultimate owner.

I use a short question list before an owner grants deeper access:

• Who is approaching me? Record the person’s role, employer, and authority to speak for the proposed buyer.
• Who would sign? Ask for the acquisition entity’s full legal name, formation jurisdiction, and relationship to NVA.
• Who funds the purchase? Identify the funding party without assuming JAB signs or guarantees the practice-level agreement.
• Who makes each promise? Tie employment, property, transition, and continuing commitments to a named entity in the documents.
• Who issues rollover equity? Identify the issuer, security class, governing agreement, and ownership level before evaluating retained value.
• What support exists? Ask whether any parent guaranty or other support is proposed, and have counsel assess its actual scope.
• What can change? Read assignment, transfer, amendment, dilution, information-rights, and change-of-control provisions in their own documents.
• What remains unresolved? Keep a written issue list rather than treating a verbal explanation as a closed item.

The end-to-end guide to selling a veterinary practice places this entity work inside the larger process. Here, the point is narrower: names allocate responsibility.

Do not infer a guaranty from ownership. An ultimate owner can sit above the acquisition entity without becoming a party to the agreement or guaranteeing every obligation beneath it.

Do not infer operating control from a family relationship either. Published records describe the Reimann family as controlling JAB, not as directly managing NVA hospitals or individual transactions.

The cleanest file has a one-page entity chart, a marked list of documents, and no unexplained jump between “NVA” in conversation and another name on the signature page.

How should a seller evaluate rollover equity and a future platform event in 2026?

Treat rollover equity as an investment decision, not delayed cash with a known payday. Its issuer, ownership level, rights, dilution, transfer limits, information access, and treatment in a future platform event all matter.

No one can promise appreciation, control, liquidity, timing, or a second payout. Evaluate only the rights written in the governing documents and the assumptions you can support.

Rollover equity is retained investment value tied to the buyer or platform after closing. It may sit in an entity different from the one buying the practice.

A liquidity event is a transaction that may let an investor convert some or all of an interest into cash. Whether that happens, when, and on what terms depends on the event and governing documents.

Ask what happens under a sale, recapitalization, transfer, reorganization, or public listing. Those questions are scenarios for document review, not claims that any specific NVA event is planned.

CFO.com describes a continuation vehicle as a structure that moves a portfolio company from one fund into a new vehicle managed by the same firm, while existing investors may cash out or continue.

Its reporting said the median conventional PE holding period reached nearly 6 years in 2025, the longest in 25 years of tracking. That industry statistic does not establish JAB’s horizon or NVA’s next step.

Veterinary consolidation already offers an industry example. On November 3, 2025, Tyree & D’Angelo Partners announced a single-asset continuation fund for Western Veterinary Partners.

The sponsor said the structure extended its partnership and added capital for Western’s growth and acquisition strategy. This was Western’s transaction, not NVA’s, and the distinction matters.

That example matters because it shows why “future exit” is too narrow a phrase. An investment can be sold, rolled, reorganized, or carried into a different vehicle, and each path can treat minority holders differently.

The questions I want answered are specific:

• Issuer. Which legal entity issues the rollover interest, and where does it sit in the ownership chain?
• Security. What class is issued, and how do its economic and voting rights compare with other classes?
• Dilution. What future issuances or financing events can dilute the interest?
• Information. What financial and operating information must the issuer provide, and how often?
• Transfer. Which restrictions, repurchase rights, drag rights, tag rights, or approval requirements apply?
• Event treatment. How would a sale, recapitalization, continuation vehicle, reorganization, or listing affect the interest?
• Tax review. What does the actual structure mean for this seller, based on independent tax advice?

If the answer arrives only as “you may get another bite later,” the diligence is not done. A metaphor cannot replace the security, capitalization, governing agreement, or event provisions.

What should an owner do after receiving NVA outreach in 2026?

Confirm the caller, protect confidential information, identify the proposed acquisition entity, and decide whether NVA should enter a controlled process with other qualified buyers.

Keep the ownership chart beside the process documents. A recognized platform can be a credible participant without becoming the only comparison or replacing diligence on the actual offer.

First, acknowledge the outreach without opening the practice file. Confirm who contacted you, what organization employs that person, and what information is being requested.

Next, decide whether a sale conversation fits your timing. The guide to choosing who should buy your veterinary practice helps frame fit without turning one ownership fact into a recommendation.

Then control access. In our Elite Selling System, we hand-select and vet every buyer allowed to bid, the way a doorman with a velvet rope admits only the right people.

The NVA conversation can proceed inside that controlled group. Qualification earns a place in the process; it does not earn unrestricted access to records, team details, or operating information.

Compare complete proposals, not logos. Keep price, rollover, obligations, entity support, timing, and seller responsibilities in one review, with legal and tax advisers examining their own areas.

Ownership diligence runs beside that comparison. It tells you where approvals, promises, retained investment, and future-event exposure may sit.

If NVA has contacted you and you want to understand the ownership chain before sharing more, request a free, confidential NVA offer review. Bring the letter, the entity names, and every document you have received.

The question across the table is still simple. “Who is on the other side?” deserves an answer that reaches the signature block, not one that stops at the logo.

---

Frequently asked questions for veterinary practice owners in 2026

Who owns NVA in 2026?

Current company and sponsor records keep NVA in JAB’s ownership orbit. JAB is the ultimate owner and investor; NVA is the operating company.

Public records do not establish every shareholding or exclude management ownership.

Is NVA owned by JAB or the Reimann family in 2026?

JAB owns NVA, and published records describe JAB as controlled by the Reimann family. That does not mean the family directly manages NVA’s veterinary operations; NVA remains the operating company with its own leadership.

Are NVA and Ethos the same operating company in 2026?

No. NVA separated its general-practice operations from the Ethos specialty-and-emergency platform in 2023.

Current NVA materials still present both within the broader group, but sellers should verify the exact entities involved.

Is JAB a conventional private equity fund in 2026?

No. Published records describe JAB as a privately held, family-controlled investment group or holding company.

Sellers should not assign it an assumed exit deadline or holding period based on a conventional fund model.

Do the FTC orders apply to every NVA practice sale in 2026?

No. The 2022 FTC provisions concern covered specialty-and-emergency acquisitions within specified distances and jurisdictions.

They do not universally restrict NVA purchases of companion-animal general practices; counsel should test the proposed transaction.

What is rollover equity in an NVA transaction in 2026?

Rollover equity is retained investment value tied to the buyer or platform after closing. Its rights and future value depend on the documents; appreciation, control, timing, liquidity, and a later payout are never guaranteed.

Could NVA’s ownership change after a practice sale in 2026?

Yes, but no specific NVA transaction should be assumed. A seller should ask how rollover equity and continuing obligations would be treated in a sale, recapitalization, transfer, or other liquidity event.

What should I do after NVA contacts my practice in 2026?

Confirm the caller, protect confidential information, identify the acquisition entity, and decide whether NVA should enter a controlled process with other qualified buyers. A brand name cannot replace review of the actual entities and documents.

---

Sources

NVA ownership and operating structure

1. PE Professional. “Ares and OMERS Sell NVA to JAB.” June 17, 2019. peprofessional.com
2. American Veterinary Medical Association. “NVA Clinics Purchased by German-Owned Company.” August 14, 2019. avma.org
3. American Veterinary Medical Association. “NVA Splits Into Two Businesses, May Go Public in Next Few Years.” May 15, 2023. avma.org
4. National Veterinary Associates. “National Veterinary Associates.” Accessed July 17, 2026. nva.com
5. National Veterinary Associates. “National Veterinary Associates Names John G. Bruno Chief Executive Officer.” September 8, 2025. nva.com
6. JAB Holding Company. “News.” Accessed July 17, 2026. jabholco.com

Regulatory records and analysis

7. Paul Hastings. “Considerations for Private Equity After FTC Vet Clinic Deal.” 2022. paulhastings.com
8. American Veterinary Medical Association. “Firm’s ‘Anticompetitive Acquisition’ of Veterinary Clinics Prompts FTC Actions.” 2022. avma.org

Ownership-event mechanics and veterinary illustration

9. CFO.com. “Will Private Equity’s Pivot to Continuation Vehicles Continue in 2026?” 2026. cfo.com
10. Tyree & D’Angelo Partners. “TDP Announces Single-Asset Continuation Fund of Western Veterinary Partners.” November 3, 2025. tdpfund.com